Company intelligence / Profile preview

Milex Capital

United Statesdnb.com ↗
Ownership
Private
Employees
~200
Development stage
Other
01

Overview

Milex was a leading supplier of women’s healthcare products including pessaries for urinary incontinence and pelvic support, cancer screening devices, breast biopsy needles, and patient education materials. The company was acquired by CooperSurgical (a unit of Cooper Companies). At the time of acquisition it had about 200 employees and served over 20,000 healthcare providers.

Therapeutic areas
OncologyWomen's Health
Modalities
Device
Industry
Therapeutic Medical Devices
02

Partnerships

Integrated into CooperSurgical's distribution network

Beyond the preview

Go deeper on Milex Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Milex Capital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call